Shopping Cart
- Remove All
- Your shopping cart is currently empty
Relutrigine (PRAX-562), an orally active persistent sodium channel inhibitor, potently and selectively targets persistent I Na, induced either by ATX-II (Nav 1.5 activator) or SCN8A mutation N1768D, with IC 50 values of 141 nM and 75 nM, respectively. Demonstrating a potent use-dependent block, it effectively reduces neuronal intrinsic excitability and exhibits significant anticonvulsant activity.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 1.586 € | 6-8 weeks | |
50 mg | 2.071 € | 6-8 weeks | |
100 mg | 2.660 € | 6-8 weeks |
Description | Relutrigine (PRAX-562), an orally active persistent sodium channel inhibitor, potently and selectively targets persistent I Na, induced either by ATX-II (Nav 1.5 activator) or SCN8A mutation N1768D, with IC 50 values of 141 nM and 75 nM, respectively. Demonstrating a potent use-dependent block, it effectively reduces neuronal intrinsic excitability and exhibits significant anticonvulsant activity. |
Alias | PRAX-562 |
Molecular Weight | 407.27 |
Formula | C15H11F6N5O2 |
Cas No. | 2392951-29-8 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.